Bard Associates Inc Neogenomics Inc Transaction History

Bard Associates Inc

$250 Million
Q4 2024

A detailed history of Bard Associates Inc transactions in Neogenomics Inc stock. As of the latest transaction made, Bard Associates Inc holds 47,405 shares of NEO stock, worth $465,517. This represents 0.31% of its overall portfolio holdings.

Number of Shares

47,405

Previous 47,605 0.42%

Holding current value

$465,517

Previous $702,000 11.25%

% of portfolio

0.31%

Previous 0.26%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 06, 2025	SELL	$13.0 - $18.43 $2,600 - $3,686	-200 Reduced 0.42%	47,405 $781,000
Q3 2024 Nov 06, 2024	SELL	$13.4 - $17.73 $2,144 - $2,836	-160 Reduced 0.33%	47,605 $702,000
Q4 2023 Feb 13, 2024	SELL	$11.67 - $20.73 $8,169 - $14,511	-700 Reduced 1.44%	47,765 $772,000
Q2 2022 Aug 11, 2022	BUY	$7.06 - $13.97 $5,400 - $10,687	765 Added 1.6%	48,465 $395,000
Q4 2021 Feb 14, 2022	SELL	$30.49 - $48.49 $134,156 - $213,356	-4,400 Reduced 8.45%	47,700 $1.63 Million
Q2 2021 Aug 12, 2021	SELL	$36.62 - $51.69 $1.4 Million - $1.97 Million	-38,100 Reduced 42.24%	52,100 $2.35 Million
Q1 2021 May 13, 2021	SELL	$41.56 - $59.88 $54,028 - $77,844	-1,300 Reduced 1.42%	90,200 $4.35 Million
Q4 2020 Feb 11, 2021	SELL	$36.08 - $56.47 $10,824 - $16,941	-300 Reduced 0.33%	91,500 $4.93 Million
Q3 2020 Nov 12, 2020	SELL	$33.26 - $40.48 $6,652 - $8,095	-200 Reduced 0.22%	91,800 $3.39 Million
Q1 2020 May 13, 2020	SELL	$20.5 - $34.53 $297,250 - $500,685	-14,500 Reduced 13.62%	92,000 $2.54 Million
Q4 2019 Feb 13, 2020	BUY	$18.96 - $29.84 $7.18 Million - $11.3 Million	378,600 Added 336.53%	491,100 $2.05 Million
Q4 2019 Feb 13, 2020	SELL	$18.96 - $29.84 $7.29 Million - $11.5 Million	-384,600 Reduced 78.31%	106,500 $3.12 Million
Q3 2019 Nov 14, 2019	SELL	$19.12 - $26.24 $15,296 - $20,992	-800 Reduced 0.71%	112,500 $2.15 Million
Q2 2019 Aug 13, 2019	SELL	$19.57 - $24.1 $111,549 - $137,370	-5,700 Reduced 4.79%	113,300 $2.49 Million
Q1 2019 May 13, 2019	SELL	$12.14 - $20.46 $176,637 - $297,693	-14,550 Reduced 10.89%	119,000 $2.44 Million
Q4 2018 Feb 13, 2019	SELL	$11.24 - $18.5 $707,479 - $1.16 Million	-62,943 Reduced 32.03%	133,550 $1.68 Million
Q3 2018 Nov 14, 2018	SELL	$12.5 - $15.38 $14,250 - $17,533	-1,140 Reduced 0.58%	196,493 $3.02 Million
Q2 2018 Aug 15, 2018	SELL	$7.99 - $14.05 $390,311 - $686,342	-48,850 Reduced 19.82%	197,633 $2.59 Million
Q1 2018 May 14, 2018	SELL	$7.23 - $8.76 $50,610 - $61,320	-7,000 Reduced 2.76%	246,483 $2.01 Million
Q4 2017 Feb 13, 2018	SELL	$8.02 - $11.18 $25,182 - $35,105	-3,140 Reduced 1.22%	253,483 $2.25 Million
Q3 2017 Nov 14, 2017	BUY	$9.11 - $11.26 $2.34 Million - $2.89 Million	256,623	256,623 $2.86 Million

Others Institutions Holding NEO

# of Institutions

282

Shares Held

124M

Call Options Held

751K

Put Options Held

107K

View Full List

About NEOGENOMICS INC

Ticker NEO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 125,796,000
Market Cap $1.24B
Description
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...

More about NEO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bard Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bard Associates Inc with notifications on news.

Account

Bard Associates Inc Neogenomics Inc Transaction History